Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies
Tuberculosis (TB) is an infection caused by the pathogen Mycobacterium tuberculosis. The disease causes around 2 million deaths worldwide, and incidences of drug resistance only makes increases the number. The most vulnerable victims of TB infections are children and human immunodeficiency virus (HI...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
HH Publisher
2024
|
| Subjects: | |
| Online Access: | https://eprints.ums.edu.my/id/eprint/38830/1/ABSTRACT.pdf https://eprints.ums.edu.my/id/eprint/38830/2/FULL%20TEXT.pdf |
| _version_ | 1811136367450652672 |
|---|---|
| author | Xin, Bernadette Jie Tune Annatasha Stephen Rhanye Mac Guad Neeraj Kumar Fuloria Vetriselvan Subramaniyan Mahendran Sekar Yuan, Seng Wu |
| author_facet | Xin, Bernadette Jie Tune Annatasha Stephen Rhanye Mac Guad Neeraj Kumar Fuloria Vetriselvan Subramaniyan Mahendran Sekar Yuan, Seng Wu |
| author_sort | Xin, Bernadette Jie Tune |
| collection | UMS |
| description | Tuberculosis (TB) is an infection caused by the pathogen Mycobacterium tuberculosis. The disease causes around 2 million deaths worldwide, and incidences of drug resistance only makes increases the number. The most vulnerable victims of TB infections are children and human immunodeficiency virus (HIV) patients. TB and HIV co-infections can be deadly in AIDS sufferers, as the immune system is not able to combat TB infections, hence worsening the infection. Common drugs to treat TB are available in the market, first-line drugs such as isoniazid and rifamycin are broad-spectrum drugs. Second-line antibiotics such as fluoroquinolones are also available. In this review, the mechanisms of action of TB drugs are briefly discussed, as wells as the respective resistant mechanisms of M. tuberculosis against these drugs. An updated treatment regime for TB management using bedaquiline, pretomanid and linezolid was also discussed, which shows 90% therapeutic efficacy against highly drug-resistant tuberculosis cases. Furthermore, novel strategies such as nanoparticle-conjugated TB drugs can improve drug delivery, TB drug efficiency while reducing side effects. However, importance on patient compliance to the treatment regime is still the most crucial part of TB management, hence initiatives can be put to improve patient awareness and education. |
| first_indexed | 2024-09-24T00:49:27Z |
| format | Article |
| id | ums.eprints-38830 |
| institution | Universiti Malaysia Sabah |
| language | English English |
| last_indexed | 2024-09-24T00:49:27Z |
| publishDate | 2024 |
| publisher | HH Publisher |
| record_format | dspace |
| spelling | ums.eprints-388302024-06-12T02:08:24Z https://eprints.ums.edu.my/id/eprint/38830/ Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies Xin, Bernadette Jie Tune Annatasha Stephen Rhanye Mac Guad Neeraj Kumar Fuloria Vetriselvan Subramaniyan Mahendran Sekar Yuan, Seng Wu RC306-320.5 Tuberculosis RM265-267 Antibiotic therapy. Antibiotics Tuberculosis (TB) is an infection caused by the pathogen Mycobacterium tuberculosis. The disease causes around 2 million deaths worldwide, and incidences of drug resistance only makes increases the number. The most vulnerable victims of TB infections are children and human immunodeficiency virus (HIV) patients. TB and HIV co-infections can be deadly in AIDS sufferers, as the immune system is not able to combat TB infections, hence worsening the infection. Common drugs to treat TB are available in the market, first-line drugs such as isoniazid and rifamycin are broad-spectrum drugs. Second-line antibiotics such as fluoroquinolones are also available. In this review, the mechanisms of action of TB drugs are briefly discussed, as wells as the respective resistant mechanisms of M. tuberculosis against these drugs. An updated treatment regime for TB management using bedaquiline, pretomanid and linezolid was also discussed, which shows 90% therapeutic efficacy against highly drug-resistant tuberculosis cases. Furthermore, novel strategies such as nanoparticle-conjugated TB drugs can improve drug delivery, TB drug efficiency while reducing side effects. However, importance on patient compliance to the treatment regime is still the most crucial part of TB management, hence initiatives can be put to improve patient awareness and education. HH Publisher 2024 Article NonPeerReviewed text en https://eprints.ums.edu.my/id/eprint/38830/1/ABSTRACT.pdf text en https://eprints.ums.edu.my/id/eprint/38830/2/FULL%20TEXT.pdf Xin, Bernadette Jie Tune and Annatasha Stephen and Rhanye Mac Guad and Neeraj Kumar Fuloria and Vetriselvan Subramaniyan and Mahendran Sekar and Yuan, Seng Wu (2024) Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies. Progress In Drug Discovery & Biomedical Science. pp. 1-14. ISSN 2710-6039 https://doi.org/10.36877/pddbs.a0000438 |
| spellingShingle | RC306-320.5 Tuberculosis RM265-267 Antibiotic therapy. Antibiotics Xin, Bernadette Jie Tune Annatasha Stephen Rhanye Mac Guad Neeraj Kumar Fuloria Vetriselvan Subramaniyan Mahendran Sekar Yuan, Seng Wu Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies |
| title | Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies |
| title_full | Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies |
| title_fullStr | Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies |
| title_full_unstemmed | Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies |
| title_short | Pharmacological Management of Tuberculosis, Challenges, and Potential Strategies |
| title_sort | pharmacological management of tuberculosis challenges and potential strategies |
| topic | RC306-320.5 Tuberculosis RM265-267 Antibiotic therapy. Antibiotics |
| url | https://eprints.ums.edu.my/id/eprint/38830/1/ABSTRACT.pdf https://eprints.ums.edu.my/id/eprint/38830/2/FULL%20TEXT.pdf |
| work_keys_str_mv | AT xinbernadettejietune pharmacologicalmanagementoftuberculosischallengesandpotentialstrategies AT annatashastephen pharmacologicalmanagementoftuberculosischallengesandpotentialstrategies AT rhanyemacguad pharmacologicalmanagementoftuberculosischallengesandpotentialstrategies AT neerajkumarfuloria pharmacologicalmanagementoftuberculosischallengesandpotentialstrategies AT vetriselvansubramaniyan pharmacologicalmanagementoftuberculosischallengesandpotentialstrategies AT mahendransekar pharmacologicalmanagementoftuberculosischallengesandpotentialstrategies AT yuansengwu pharmacologicalmanagementoftuberculosischallengesandpotentialstrategies |